Viventia Biotechnologies Inc.

Calculating rank

USPTO Granted Patents = 7

% Expired Patents = 71.4

EPO Patents = 2

Forward Citations = 21

Loading Chart...

7 inventors (with patents filed for the assignee):

Jeannick Cizeau (7 out of 17 patents)

Glen MacDonald (6 out of 16 patents)

Francina C Chahal (5 out of 10 patents)

4. Nicholas Ronald Glover (2 out of 13 patents)

5. Joycelyn Entwistle (2 out of 9 patents)

6. Arjune Premsukh (1 out of 2 patents)

7. Denis Bosc (1 out of 2 patents)

8. Nicholas R Glover (0 patent)

7 patents: Sort by Forward Citations

1. 8389286 - Cancer-associated antigen (2013-03-05),

2. 8383117 - CD44E tumor specific antibody (2013-02-26),

3. 8318472 - Optimized nucleic acid sequences for the expression of VB4-845 (2012-11-27),

4. 8273550 - Antibodies against a cancer-associated epitope of variant HnRNPG and uses thereof (2012-09-25),

5. 8263744 - Binding proteins that bind to EpCAM linked to an effector molecule (2012-09-11),

6. 8084576 - Cancer associated glucose transporter 8 variant (2011-12-27),

7. 7956162 - Cancer-associated antigen (2011-06-07),

Company Overview

Viventia Biotechnologies Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. With a focus on antibody-drug conjugates and immuno-oncology treatments, Viventia aims to improve outcomes for cancer patients. Their cutting-edge research and development efforts have led to promising advancements in the fight against cancer.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#102 in Mississauga

#2,102 in Canada

Mississauga, Canada

Viventia Biotechnologies Inc.

Forward Citations = 21

7 inventors:

Jeannick Cizeau (7 out of 17 patents)

Glen MacDonald (6 out of 16 patents)

Francina C Chahal (5 out of 10 patents)

4. Nicholas Ronald Glover (2 out of 13 patents)

5. Joycelyn Entwistle (2 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Viventia Biotechnologies Inc.. Retrieved from https://idiyas.com/company/viventia-biotechnologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]